Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-27

Clinical Trial Update: Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluates the efficacy and safety of zoledronic acid for osteoporosis in men. The update provides results from that study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED